TickerFacts.

A business in context

CGON research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-14 · 0001193125-26-355561

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-336918

  3. 8-K · Current report

    Report date 2026-08-06 · 0001193125-26-336886 · Items 2.02,8.01,9.01

  4. 4 · Ownership change

    Report date 2026-07-15 · 0001193125-26-307838

  5. 4 · Ownership change

    Report date 2026-07-10 · 0001193125-26-303188

  6. 4 · Ownership change

    Report date 2026-06-25 · 0001140361-26-026779

  7. 4 · Ownership change

    Report date 2026-06-24 · 0001193125-26-282861

  8. 4 · Ownership change

    Report date 2026-06-22 · 0001193125-26-279543

  9. 4 · Ownership change

    Report date 2026-06-15 · 0001684531-26-000002

  10. 8-K · Current report

    Report date 2026-06-04 · 0001193125-26-261670 · Items 5.07

  11. 4 · Ownership change

    Report date 2026-06-04 · 0001193125-26-259705

  12. 8-K · Current report

    Report date 2026-05-20 · 0001193125-26-237908 · Items 5.02

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-214669

  14. 8-K · Current report

    Report date 2026-05-08 · 0001193125-26-213440 · Items 2.02,9.01

  15. DEF 14A · Proxy statement

    Report date 2026-04-23 · 0001193125-26-177395

  16. 8-K · Current report

    Report date 2026-04-13 · 0001193125-26-152044 · Items 5.02,9.01

  17. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-079498

  18. 8-K · Current report

    Report date 2026-02-27 · 0001193125-26-079452 · Items 2.02,9.01

  19. 8-K · Current report

    Report date 2026-01-13 · 0001193125-26-011855 · Items 8.01,9.01

  20. 8-K · Current report

    Report date 2026-01-09 · 0001193125-26-008329 · Items 7.01,8.01,9.01

  21. 8-K · Current report

    Report date 2025-11-22 · 0001193125-25-298160 · Items 5.02

  22. 8-K · Current report

    Report date 2025-11-10 · 0001193125-25-283108 · Items 5.02

  23. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-283000

  24. 8-K · Current report

    Report date 2025-11-14 · 0001193125-25-281672 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-09-09 · 0001991792-25-000007 · Items 7.01,9.01

  26. 8-K · Current report

    Report date 2025-09-05 · 0001991792-25-000004 · Items 7.01,8.01,9.01

  27. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-105855

  28. 8-K · Current report

    Report date 2025-08-08 · 0000950170-25-105487 · Items 2.02,9.01

  29. 8-K · Current report

    Report date 2025-07-07 · 0000950170-25-095296 · Items 5.02

  30. 8-K · Current report

    Report date 2025-06-05 · 0000950170-25-083088 · Items 5.07

  31. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-069831

  32. 8-K · Current report

    Report date 2025-05-13 · 0000950170-25-069825 · Items 2.02,9.01

  33. 8-K · Current report

    Report date 2025-04-26 · 0000950170-25-058956 · Items 7.01,8.01,9.01

  34. DEF 14A · Proxy statement

    Report date 2025-06-05 · 0000950170-25-058342

  35. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-046351

  36. 8-K · Current report

    Report date 2025-03-28 · 0000950170-25-046335 · Items 2.02,9.01

  37. 8-K · Current report

    Report date 2025-03-24 · 0000950170-25-043497 · Items 7.01,8.01,9.01

  38. 8-K · Current report

    Report date 2025-01-09 · 0000950170-25-004168 · Items 5.02

  39. 8-K · Current report

    Report date 2024-12-05 · 0001193125-24-271116 · Items 7.01,8.01,9.01

  40. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-124642

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 1 transaction rows1PSale: 6 transaction rows6SGrant / award: 11 transaction rows11AExercise / conversion: 12 transaction rows12MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

30 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-25
2026-06-29
Liu Brian Guan-ChyunP · Purchase
Acquired
Common Stock371085.066.87
2026-06-24
2026-06-25
POST LEONARD ES · Sale
Disposed
Common Stock5000.070.0
2026-06-24
2026-06-25
POST LEONARD EM · Exercise / conversion
Acquired
Common Stock5000.00.6
2026-06-24
2026-06-25
POST LEONARD EM · Exercise / conversion
Disposed
Director Stock Option (right to buy)
Derivative security
5000.00.0
2026-06-22
2026-06-23
POST LEONARD ES · Sale
Disposed
Common Stock5000.065.0
2026-06-22
2026-06-23
POST LEONARD EM · Exercise / conversion
Acquired
Common Stock5000.00.6
2026-06-22
2026-06-23
POST LEONARD EM · Exercise / conversion
Disposed
Director Stock Option (right to buy)
Derivative security
5000.00.0
2026-06-15
2026-06-16
Mulay James
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock654.03.72
2026-06-15
2026-06-16
Mulay James
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock1310.012.59
2026-06-15
2026-06-16
Mulay James
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1310.060.12
2026-06-15
2026-06-16
Mulay James
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock654.060.12
2026-06-15
2026-06-16
Mulay James
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Director Stock Option (right to buy)
Derivative security
654.00.0
2026-06-15
2026-06-16
Mulay James
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Director Stock Option (right to buy)
Derivative security
1310.00.0
2026-06-04
2026-06-05
POST LEONARD EM · Exercise / conversion
Acquired
Common Stock1000.00.6
2026-06-04
2026-06-05
POST LEONARD ES · Sale
Disposed
Common Stock1000.054.5
2026-06-04
2026-06-05
POST LEONARD EA · Grant / award
Acquired
Director Stock Option (right to buy)
Derivative security
9354.00.0
2026-06-04
2026-06-05
POST LEONARD EM · Exercise / conversion
Disposed
Director Stock Option (right to buy)
Derivative security
1000.00.0
2026-06-04
2026-06-05
Liu Brian Guan-ChyunA · Grant / award
Acquired
Director Stock Option (right to buy)
Derivative security
9354.00.0
2026-06-04
2026-06-05
Tong Victor Edward JrA · Grant / award
Acquired
Director Stock Option (right to buy)
Derivative security
9354.00.0
2026-06-04
2026-06-05
Mulay JamesA · Grant / award
Acquired
Director Stock Option (right to buy)
Derivative security
9354.00.0
2026-06-04
2026-06-05
Rossi ChristinaA · Grant / award
Acquired
Director Stock Option (right to buy)
Derivative security
9354.00.0
2026-06-04
2026-06-05
Graf Susan EA · Grant / award
Acquired
Director Stock Option (right to buy)
Derivative security
9354.00.0
2026-04-17
2026-04-20
Mulay JamesM · Exercise / conversion
Acquired
Common Stock15600.036.63
2026-04-17
2026-04-20
Mulay JamesS · Sale
Disposed
Common Stock15600.073.01
2026-04-17
2026-04-20
Mulay JamesM · Exercise / conversion
Disposed
Director Stock Option (right to buy)
Derivative security
15600.00.0
2026-04-15
2026-04-16
Bellete AmbawA · Grant / award
Acquired
Employee Stock Option (Right to Buy)
Derivative security
107508.00.0
2026-04-15
2026-04-16
Kasturi VijayA · Grant / award
Acquired
Employee Stock Option (Right to Buy)
Derivative security
79216.00.0
2026-04-15
2026-04-16
Patterson Joshua F.A · Grant / award
Acquired
Employee Stock Option (Right to Buy)
Derivative security
45266.00.0
2026-04-15
2026-04-16
DETORE JAMES M.A · Grant / award
Acquired
Employee Stock Option (Right to Buy)
Derivative security
90574.00.0
2026-04-15
2026-04-16
Kuan ArthurA · Grant / award
Acquired
Employee Stock Option (Right to Buy)
Derivative security
271600.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001991792CG Oncology, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$1.14M$1.21M
    2023-12-31$204.0K$223.5K

    Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

    Explore the CPI history ↗